NCT03918616View on ClinicalTrials.gov

P2X7 Receptor, Inflammation and Neurodegenerative Diseases

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 20, 2017

Primary Completion Date

December 30, 2018

Study Completion Date

March 30, 2019

Conditions
Neuro-Degenerative Disease
Interventions
DRUG

Memantine, Dopamine receptor-agonists

The study do not provide any experimental drugs. Patientes will receive treatment routinary used by Neurologist for these diseases.

Trial Locations (1)

56125

University of Pisa, Pisa

All Listed Sponsors
lead

University of Pisa

OTHER

NCT03918616 - P2X7 Receptor, Inflammation and Neurodegenerative Diseases | Biotech Hunter | Biotech Hunter